Braskem SA BAK 深 沪
等待开盘 10-14 09:30:00 美东时间
2.46
+0.080
+3.36%
华盛通- 最 高2.47
- 今 开2.43
- 成交量 65.08万股
- 最 低 2.41
- 昨 收 2.38
- 总市值 9.79亿
- 52周最高 6.409
- 市盈率 静 --
- 换手率 0.16%
- 52周最低 2.32
- 委 比 -88.89%
- 总股本 3.98亿
- 历史最高 28.3574
- 量 比 0.56
- 振 幅 2.52%
- 历史最低 -0.9159
- 每 手 1
- 风险率 1.08%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Braskem S.A. Reports September 2025 Securities Operations
Braskem SA ( ($BAK) ) has issued an announcement. In September 2025, Braskem S....
10-11 05:48
Braskem plunges as Citigroup downgrades to Neutral
Shares of Braskem (NYSE:BAK) were down over 7% after Citigroup cut rating on the petrochemical company to Neutral from Buy, citing lower sales volume. The stock was trading at $2.36 in afternoon tradi...
10-11 02:26
Braskem Addresses Takeover Speculation Amidst Market Rumors
Braskem SA ( ($BAK) ) has provided an update. On October 7, 2025, Braskem S.A. ...
10-08 18:28
Braskem Bolsters Cash Reserves Amid Industry Downturn
An update from Braskem SA ( ($BAK) ) is now available. On October 3, 2025, Bras...
10-06 19:58
Braskem taps entire $1B credit line amid debt review - Bloomberg
Braskem (NYSE:BAK) has tapped its entire $1 billion credit facility amid a downturn in Brazil's chemical industry and mounting investor concerns over the troubled company, Bloomberg reported Friday. T...
10-04 06:03
'Braskem Pulls From $1 Billion Credit Facility Amid Debt Review' -Bloomberg
https://www.bloomberg.com/news/articles/2025-10-03/braskem-pulls-from-1-billion-credit-facility-amid-debt-review?srnd=homepage-asia
10-04 03:20
Braskem Faces Credit Downgrade Amid Industry Challenges
An update from Braskem SA ( ($BAK) ) is now available. On September 29, 2025, B...
09-29 20:47
美股大行评级 | 潜在涨幅485.44%！Allarity Therapeutics获机构升目标价至9.25美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持Allarity Therapeutics"买入"评级，目标价从9美元升至9.25美元；JMP证券：维持Crinetics Pharmaceuticals"跑赢大市"评级，目标价从86美元升至143美元
09-29 09:15
Braskem plunges after hiring advisors in bid to boost finances
Braskem (NYSE:BAK) closed -14.7% in Friday's trading to its lowest close since April 2003 after saying it hired financial and legal advisors to find ways to improve its capital structure, as it strugg...
09-27 06:23
UBS Downgrades Braskem to Neutral, Lowers Price Target to $3.8
UBS analyst Tasso Vasconcellos downgrades Braskem (NYSE: BAK) from Buy to Neutral and lowers the price target from $5.1 to $3.8.
09-26 19:18
